I wish I coud agree. Remoxy is not much revenue for Durect - if approval would even occur.
The 7.1 million shares ssued in Nov to unknown buyer is problematic. Buyer is getting his 30% return and the small investor getting hosed. Best we can do is hope for 2/12 approval and post these messages which have zero impact on the pps.